Top Injectable Manufacturer in Iraq – Reliable Pharmaceutical Solutions
- Maulik Sudani
- 3 hours ago
- 9 min read
Last Updated: July 16, 2026
TL;DR: Iraq — a nation of more than 47 million people whose health system is rebuilding across federal governorates and the Kurdistan Region, running from teaching hospitals in Baghdad, Basra, Mosul and Erbil down to general and district hospitals and primary health centres, and which imports the large majority of its finished pharmaceuticals and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of sterile injectables. Every imported sterile injectable must be registered with the Ministry of Health (MoH), be handled by a locally licensed scientific bureau or agent, be filed in Common Technical Document (CTD) format, be supported by a Certificate of Pharmaceutical Product and a WHO-GMP certificate, have its manufacturing site registered with the MoH (or the Kurdistan Medicines Control Agency in the Kurdistan Region), pass National Center for Drug Control and Research (NCDCR) quality testing, and carry Arabic labelling. Much of the public-sector volume is bought and imported through KIMADIA, the State Company for Marketing Drugs and Medical Appliances. Farbe Firma Pvt Ltd is a WHO-GMP certified injectable manufacturer in Iraq's supply chain and a CDMO in Gujarat, India, producing more than 100 sterile injectables under ISO Class 5 aseptic conditions and exporting to 30+ countries, with complete CTD/eCTD dossiers, drug master files and ICH stability data ready to support MoH registration, NCDCR release and KIMADIA and hospital procurement for Iraqi partners.
Key Takeaways
Market and regulatory pathway: every imported sterile injectable must be registered with the Ministry of Health (MoH), be handled by a locally licensed scientific bureau or agent, be filed in CTD format, have its manufacturing site registered, and be backed by a Certificate of Pharmaceutical Product and a WHO-GMP certificate; Farbe Firma builds every dossier and supply arrangement around MoH and NCDCR requirements and the public demand channelled through KIMADIA, the State Company for Marketing Drugs and Medical Appliances.
Certified manufacturing: WHO-GMP certified plant with an ISO Class 5 aseptic core, validated water-for-injection loops, terminal moist-heat sterilisation where the formulation qualifies and full aseptic processing where it does not, HPLC and LAL testing and 100% visual inspection on every batch.
CTD dossier support: full CTD/eCTD modules, ICH Q1A long-term and accelerated stability and ICH Q1B photostability data generated for Iraq's hot, dry Climatic Zone III (with Zone IVb data for the humid south), sterilisation and container-closure packages, drug master files and Certificate-of-Pharmaceutical-Product documentation for MoH registration, NCDCR quality release and KIMADIA and hospital tenders.
End-to-end CDMO services: contract and third-party manufacturing across 100+ sterile injectables — ampoules, vials, lyophilised products and pre-filled presentations — with Arabic artwork and leaflets, tamper-evident tender-ready packaging and import/export coordination through the port of Umm Qasr near Basra and onward to Baghdad and the governorates.
Introduction: Why an Injectable Manufacturer in Iraq Must Meet Global Standards
Iraq serves more than 47 million people through a health system that is being rebuilt and expanded across the federal governorates and the Kurdistan Region, running from major teaching hospitals in Baghdad, Basra, Mosul and Erbil down to governorate general hospitals, district hospitals and primary health-care centres, coordinated by the Ministry of Health. Across all of them the demand for sterile injectables is immense — antibiotics, anaesthetics, emergency and critical-care drugs, oncology therapies, analgesics, anti-emetics, and maternal- and child-health products. Every one of them has to reach hospitals and clinics sterile, correctly labelled and exactly to specification, batch after batch, whether it is destined for a teaching hospital in Baghdad or a district hospital in Anbar, Nineveh or Dhi Qar. With a young, growing population and a large burden of both communicable and non-communicable disease, Iraq's health security depends on a dependable and resilient injectable supply.
Because Iraq has only a limited domestic manufacturing base, it imports the large majority of its finished sterile injectables and almost all of its active pharmaceutical ingredients, which makes a reliable overseas manufacturing partner strategically important. That partner must clear a demanding regulatory pathway: every product must be registered with the Ministry of Health (MoH); a locally licensed scientific bureau or agent must handle registration and importation; the dossier must be prepared in the Common Technical Document (CTD) format; the manufacturing site must be registered with the MoH (or, for the Kurdistan Region, the Kurdistan Medicines Control Agency) and hold a valid WHO-GMP certificate together with a Certificate of Pharmaceutical Product; imported batches are subject to quality testing by the National Center for Drug Control and Research (NCDCR); and labelling must suit the market in Arabic. Much of the public-sector supply is procured and imported through KIMADIA, the State Company for Marketing Drugs and Medical Appliances, whose tenders carry their own documentation requirements. An injectable manufacturer that wants to serve Iraq well has to treat these requirements not as afterthoughts but as core design inputs, which is exactly how Farbe Firma approaches the market.
What Sets a World-Class Injectable Manufacturer in Iraq Apart
The first differentiator is genuine sterile-manufacturing capability. A world-class injectable manufacturer serving Iraq runs a WHO-GMP certified plant with an ISO Class 5 (Grade A) aseptic core, validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, and both terminal moist-heat sterilisation and full aseptic processing so that each product is made by the route its formulation and container actually justify. It backs that with a proper analytical laboratory — stability-indicating HPLC assay and related-substance control, bacterial endotoxin testing by LAL, sterility testing, and particulate and container-closure-integrity checks — and a broad portfolio of more than 100 injectables in ampoule, vial, lyophilised and pre-filled formats, so an Iraqi scientific bureau, hospital or distributor can consolidate many product needs with a single qualified source. Because imported batches are tested by the NCDCR before release, a manufacturer whose certificates of analysis and documentation stand up to independent laboratory scrutiny is a genuine asset.
The second differentiator is registration and market-access support built specifically around Iraq. Because the MoH reviews dossiers in CTD format, a strong partner prepares complete, review-ready CTD/eCTD modules with ICH Q1A stability and ICH Q1B photostability data, drug master files, sterilisation and container-closure reports, method-validation packages, a Certificate of Pharmaceutical Product and a WHO-GMP certificate — the documentation a local scientific bureau's regulatory team needs to obtain and maintain a marketing authorisation and to register the manufacturing site. It supplies Arabic artwork and package inserts and packages products to compete in public procurement, where KIMADIA runs the tenders through which the public sector buys and imports medicines and where inclusion on the national Essential Medicines List shapes demand. Because Iraq is a large, price-sensitive market with a strong tender culture and NCDCR quality gate, the right partner also helps its Iraqi agent assemble every certificate and sample the tender and the laboratory will ask for. This combination of manufacturing depth and Iraq-specific dossier, labelling and tender support is what separates a true injectable manufacturer in Iraq's supply chain from a mere exporter.
Quality Systems Behind Every Batch We Ship to Iraq
Every Farbe Firma injectable batch destined for Iraq is released only after a full stack of quality checks: stability-indicating HPLC assay against pharmacopoeial reference standards, control of related substances and degradation products, solution pH and clarity, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule, vial or pre-filled format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release, so a local scientific bureau's regulatory-affairs team and the NCDCR reviewers who test imported batches can see a complete, auditable chain from raw material to finished unit.
Around those release tests sits a deeper quality architecture: validated water-for-injection systems, qualified and monitored cleanrooms, validated sterilisation and depyrogenation equipment, validated filling lines with 100% inspection, and an electronic batch-record system tied into formal deviation, change-control and CAPA workflows. Stability is tracked under long-term conditions appropriate to Iraq's predominantly hot, dry climate — the ICH Climatic Zone III condition of 30 °C / 35 % RH — with Zone IVb (30 °C / 75 % RH) data for products distributed to the humid far south around Basra and the Gulf, alongside accelerated (40 °C / 75 % RH) testing and a photostability challenge where relevant, so registered shelf lives are supported by data generated under conditions that reflect how the product will actually be stored and transported — from the port of Umm Qasr up to Baghdad, Erbil and the governorates through very high summer temperatures.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Iraq for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, spanning antibiotic, anaesthesia, emergency and critical-care, gastrointestinal, anti-emetic, analgesic, vitamin and specialty ranges — the categories Iraqi hospitals, scientific bureaus and public institutions buy in the largest volumes. For Iraqi partners we supply finished sterile injectables ready for Ministry of Health registration, with market-specific strengths, fill volumes, Arabic artwork and tamper-evident tender packs available under contract-manufacturing agreements, and every batch released to WHO-GMP standards with its CTD data package and Certificate of Pharmaceutical Product ready for the scientific bureau's marketing-authorisation filing and for NCDCR quality release.
Our CDMO services scale cleanly from a single distributor's launch portfolio to full KIMADIA and hospital-tender supply. We prepare complete CTD/eCTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substance method-validation data, sterilisation and container-closure reports, a Certificate of Pharmaceutical Product and a WHO-GMP certificate, and Arabic inserts and artwork. Our regulatory, manufacturing and logistics teams coordinate registration timelines, site registration, line slots and shipping to the port of Umm Qasr and onward to Baghdad, Basra, Erbil and the governorates as a single, managed programme rather than a series of disconnected transactions — and, because we already export to 30+ countries, our partners inherit documentation and processes that are used to satisfying strict tender and laboratory review.
Buyers stay with Farbe Firma because of audit-readiness and communication. Iraqi scientific bureaus, distributors and their auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical and regulatory queries with primary data rather than slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, sterile-process design, stability strategy for a hot Zone III climate, CTD dossier structure, MoH registration and site-registration steps, NCDCR testing and KIMADIA tender documentation in real detail. For a scientific bureau, hospital or distributor that has to answer to the Ministry of Health, to the NCDCR laboratory and to its own patients, that transparency is exactly what makes a distant manufacturer feel like a dependable local partner.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Iraq?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures more than 100 sterile injectables at its Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, terminal and aseptic sterilisation routes, HPLC and LAL testing, 100% inspection and continuous environmental monitoring. We already export to 30+ countries and prepare every batch and dossier to support import and Ministry of Health (MoH) registration in Iraq through a locally licensed scientific bureau or agent, with the WHO-GMP certificate and Certificate of Pharmaceutical Product the MoH and NCDCR require.
How does Farbe Firma support Ministry of Health drug registration in Iraq?
We provide complete CTD/eCTD modules with drug master files, ICH Q1A stability (for hot-dry Climatic Zone III, with Zone IVb data where needed) and ICH Q1B photostability data, sterilisation and container-closure reports, method-validation packages, a Certificate of Pharmaceutical Product and a WHO-GMP certificate, which is the technical documentation a local scientific bureau's regulatory team needs to register the product and the manufacturing site with the Ministry of Health (MoH). We also supply Arabic artwork and package inserts, support the National Center for Drug Control and Research (NCDCR) batch-testing and release process, and help maintain registrations through their renewal cycle.
Can Farbe Firma supply injectables for KIMADIA and Iraqi hospital tenders?
Yes. Much of Iraq's public-sector demand is procured and imported through KIMADIA, the State Company for Marketing Drugs and Medical Appliances, whose tenders carry specific documentation requirements, alongside governorate and hospital purchasing and the Kurdistan Region. We package products to be tender-ready — with the right strengths, fill volumes, Arabic artwork and tamper-evident presentations — and provide the registration dossier, WHO-GMP evidence, Certificate of Pharmaceutical Product and samples that a local scientific bureau or agent needs to compete and to clear NCDCR testing.
Which injectables can Farbe Firma supply to Iraqi hospitals and tenders?
Our portfolio of 100+ sterile injectables covers antibiotics, anaesthetics, emergency and critical-care drugs, analgesics, anti-emetics, gastrointestinal agents, vitamins and specialty products in ampoule, vial, lyophilised and pre-filled formats. We package products to be tender-ready for KIMADIA, governorate and public-hospital procurement and private hospital groups across both the federal governorates and the Kurdistan Region, with market-specific strengths and pack sizes available under contract.
What is the minimum order quantity for injectable contract manufacturing for Iraq?
MOQs vary by product, format, sterilisation route, label complexity and dossier requirements. We accommodate single-distributor launch quantities as well as full KIMADIA tender-scale supply for the Iraqi market, including the Kurdistan Region. Contact director@farbefirma.org for a specific quotation and a registration and supply plan for your product list.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments